Oralin (Sertraline)

Sertraline, the active ingredient in Oralin, is a selective serotonin reuptake inhibitor presented as a tablet for oral use. It is commonly prescribed for depressive disorders, anxiety disorders, and certain other mental health conditions in adults.

GNH USA supplies Oralin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oralin (sertraline) acts on the serotonergic pathway and is indicated for several psychiatric conditions. - Major depressive disorder: alleviates depressive symptoms and improves mood. - Obsessive‑compulsive disorder: reduces intrusive thoughts and compulsive behaviors. - Panic disorder: decreases frequency and severity of panic attacks. - Social anxiety disorder: lessens fear of social situations and improves functioning. - Post‑traumatic stress disorder: helps control re‑experiencing symptoms and hyperarousal.

Sertraline may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset that often improves with continued use. - Headache: occasional tension‑type headache. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation. - Diarrhea: loose stools. - Sexual dysfunction: decreased libido or difficulty achieving orgasm.

Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, muscle rigidity, and autonomic instability. - Suicidal thoughts: emergence of new or worsening suicidal ideation, especially early in treatment. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Hyponatremia: low blood sodium presenting with confusion or weakness. - Abnormal bleeding: increased bruising or prolonged bleeding time.

When prescribing sertraline, clinicians should consider several safety aspects. - Pregnancy: discuss potential risks and benefits; limited data suggest careful use may be warranted. - Breastfeeding: sertraline passes into milk; evaluate infant risk versus maternal benefit. - Drug‑induced QT prolongation: monitor in patients with cardiac risk factors. - Hepatic impairment: dose adjustment may be needed in severe liver disease. - Concomitant serotonergic agents: avoid combined use to reduce serotonin syndrome risk. - Store at ambient temperature: keep below 25°C, retain original packaging, and protect from moisture.

Sertraline interacts with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Pimozide: can cause severe cardiac effects. - Triptans: increased serotonin syndrome potential.

Moderate Interactions (Monitor Closely): - NSAIDs and anticoagulants: heightened bleeding risk. - Antiplatelet agents: may increase bruising. - CYP2C19 inhibitors (e.g., fluoxetine): may raise sertraline levels. - Alcohol: may enhance CNS depression. - Other serotonergic antidepressants: require dose adjustments and monitoring.